Human medicines European public assessment report (EPAR): Tygacil, tigecycline, Bacterial Infections,Skin Diseases, Bacterial,Soft Tissue Infections, Date of authorisation: 24/04/2006, Revision: 28, Status: Authorised

Case Medical Research ◽

10.31525/cmr-ac38fa ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Bacterial Infections ◽

Skin Diseases ◽

Soft Tissue Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Tygacil, tigecycline, Bacterial Infections,Skin Diseases, Bacterial,Soft Tissue Infections, Date of authorisation: 24/04/2006, Revision: 29, Status: Authorised

Case Medical Research ◽

10.31525/cmr-ac564c ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Bacterial Infections ◽

Skin Diseases ◽

Soft Tissue Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Cubicin, daptomycin, Gram-Positive Bacterial Infections,Bacteremia,Soft Tissue Infections,Endocarditis, Bacterial, Date of authorisation: 19/01/2006, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-babd56 ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Bacterial Infections ◽

Soft Tissue Infections ◽

Gram Positive ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime / avibactam, Pneumonia, Bacterial,Soft Tissue Infections,Pneumonia,Urinary Tract Infections,Gram-Negative Bacterial Infections, Date of authorisation: 23/06/2016, Revision: 7, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871f8 ◽

2019 ◽

Author(s):

Keyword(s):

Urinary Tract ◽

Soft Tissue ◽

Urinary Tract Infections ◽

Bacterial Infections ◽

Soft Tissue Infections ◽

Gram Negative ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 22/03/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-399669 ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Skin Diseases ◽

Soft Tissue Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Orbactiv, oritavancin, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 18/03/2015, Revision: 7, Status: Authorised

Case Medical Research ◽

10.31525/cmr-587236 ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Skin Diseases ◽

Soft Tissue Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Orbactiv, oritavancin, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 18/03/2015, Revision: 5, Status: Authorised

Case Medical Research ◽

10.31525/cmr-3c3da1 ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Skin Diseases ◽

Soft Tissue Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 22/03/2017, Revision: 5, Status: Authorised

Case Medical Research ◽

10.31525/cmr-91357d ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Skin Diseases ◽

Soft Tissue Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 23/03/2015, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-95e8ec ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Skin Diseases ◽

Soft Tissue Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Xydalba, dalbavancin, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 19/02/2015, Revision: 8, Status: Authorised

Case Medical Research ◽

10.31525/cmr-cdebc1 ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Skin Diseases ◽

Soft Tissue Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Xydalba, dalbavancin, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 19/02/2015, Revision: 8, Status: Authorised

Case Medical Research ◽

10.31525/cmr-cd9d6e ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Skin Diseases ◽

Soft Tissue Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text